VERA logo

Vera Therapeutics (VERA) EBIT

annual EBIT:

-$167.17M-$74.97M(-81.31%)
December 31, 2024

Summary

  • As of today (July 1, 2025), VERA annual earnings before interest & taxes is -$167.17 million, with the most recent change of -$74.97 million (-81.31%) on December 31, 2024.
  • During the last 3 years, VERA annual EBIT has fallen by -$134.58 million (-412.98%).
  • VERA annual EBIT is now -1316.45% below its all-time high of -$11.80 million, reached on December 31, 2019.

Performance

VERA EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVERAincome statement metrics

quarterly EBIT:

-$49.90M-$8.35M(-20.09%)
March 31, 2025

Summary

  • As of today (July 1, 2025), VERA quarterly earnings before interest & taxes is -$49.90 million, with the most recent change of -$8.35 million (-20.09%) on March 31, 2025.
  • Over the past year, VERA quarterly EBIT has dropped by -$23.43 million (-88.47%).
  • VERA quarterly EBIT is now -1936.82% below its all-time high of -$2.45 million, reached on March 31, 2020.

Performance

VERA quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVERAincome statement metrics

TTM EBIT:

-$167.95M-$23.43M(-16.21%)
March 31, 2025

Summary

  • As of today (July 1, 2025), VERA TTM earnings before interest & taxes is -$167.95 million, with the most recent change of -$23.43 million (-16.21%) on March 31, 2025.
  • Over the past year, VERA TTM EBIT has dropped by -$78.46 million (-87.68%).
  • VERA TTM EBIT is now -6754.98% below its all-time high of -$2.45 million, reached on March 31, 2020.

Performance

VERA TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherVERAincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

VERA EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-81.3%-88.5%-87.7%
3 y3 years-413.0%-194.1%-274.5%
5 y5 years-1316.5%-1936.8%-2703.3%

VERA EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-413.0%at low-238.9%at low-199.2%at low
5 y5-year-1316.5%at low-1351.9%at low-2703.3%at low
alltimeall time-1316.5%at low-1936.8%at low-6755.0%at low

VERA EBIT History

DateAnnualQuarterlyTTM
Mar 2025
-
-$49.90M(+20.1%)
-$167.95M(+16.2%)
Dec 2024
-$167.17M(+81.3%)
-$41.55M(-7.0%)
-$144.52M(+13.3%)
Sep 2024
-
-$44.70M(+40.6%)
-$127.57M(+25.0%)
Jun 2024
-
-$31.80M(+20.1%)
-$102.03M(+14.0%)
Mar 2024
-
-$26.48M(+7.6%)
-$89.48M(-2.9%)
Dec 2023
-$92.20M(+4.7%)
-$24.60M(+28.4%)
-$92.20M(-7.3%)
Sep 2023
-
-$19.16M(-0.5%)
-$99.44M(-5.1%)
Jun 2023
-
-$19.25M(-34.1%)
-$104.81M(+4.5%)
Mar 2023
-
-$29.20M(-8.3%)
-$100.29M(+13.9%)
Dec 2022
-$88.06M
-$31.84M(+29.8%)
-$88.06M(+20.6%)
Sep 2022
-
-$24.53M(+66.6%)
-$73.05M(+30.1%)
DateAnnualQuarterlyTTM
Jun 2022
-
-$14.72M(-13.2%)
-$56.13M(+25.2%)
Mar 2022
-
-$16.97M(+0.8%)
-$44.84M(+37.6%)
Dec 2021
-$32.59M(-38.8%)
-$16.83M(+121.1%)
-$32.59M(-44.4%)
Sep 2021
-
-$7.61M(+121.4%)
-$58.62M(+5.8%)
Jun 2021
-
-$3.44M(-27.1%)
-$55.41M(-0.2%)
Mar 2021
-
-$4.71M(-89.0%)
-$55.51M(+4.3%)
Dec 2020
-$53.25M(+351.2%)
-
-
Dec 2020
-
-$42.86M(+875.0%)
-$53.25M(+412.6%)
Sep 2020
-
-$4.40M(+24.1%)
-$10.39M(+73.4%)
Jun 2020
-
-$3.54M(+44.5%)
-$5.99M(+144.5%)
Mar 2020
-
-$2.45M
-$2.45M
Dec 2019
-$11.80M
-
-

FAQ

  • What is Vera Therapeutics annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Vera Therapeutics?
  • What is Vera Therapeutics annual EBIT year-on-year change?
  • What is Vera Therapeutics quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Vera Therapeutics?
  • What is Vera Therapeutics quarterly EBIT year-on-year change?
  • What is Vera Therapeutics TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Vera Therapeutics?
  • What is Vera Therapeutics TTM EBIT year-on-year change?

What is Vera Therapeutics annual earnings before interest & taxes?

The current annual EBIT of VERA is -$167.17M

What is the all time high annual EBIT for Vera Therapeutics?

Vera Therapeutics all-time high annual earnings before interest & taxes is -$11.80M

What is Vera Therapeutics annual EBIT year-on-year change?

Over the past year, VERA annual earnings before interest & taxes has changed by -$74.97M (-81.31%)

What is Vera Therapeutics quarterly earnings before interest & taxes?

The current quarterly EBIT of VERA is -$49.90M

What is the all time high quarterly EBIT for Vera Therapeutics?

Vera Therapeutics all-time high quarterly earnings before interest & taxes is -$2.45M

What is Vera Therapeutics quarterly EBIT year-on-year change?

Over the past year, VERA quarterly earnings before interest & taxes has changed by -$23.43M (-88.47%)

What is Vera Therapeutics TTM earnings before interest & taxes?

The current TTM EBIT of VERA is -$167.95M

What is the all time high TTM EBIT for Vera Therapeutics?

Vera Therapeutics all-time high TTM earnings before interest & taxes is -$2.45M

What is Vera Therapeutics TTM EBIT year-on-year change?

Over the past year, VERA TTM earnings before interest & taxes has changed by -$78.46M (-87.68%)
On this page